475
Views
79
CrossRef citations to date
0
Altmetric
Original Article

YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease

, , , , , , , , & show all
Pages 295-302 | Received 10 Feb 2008, Published online: 12 Jul 2009

References

  • Jialal I, Devaraj S. Role of C-reactive protein in the assessment of cardiovascular risk. Am J Cardiol. 2003; 91: 200–2
  • Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, et al. Inflammation and long-term mortality after non–ST-elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation. 2002; 105: 1412–5
  • Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001; 285: 2481–5
  • Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation. 2002; 105: 2595–9
  • Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Review. Serum YKL-40, a new prognostic biomarker in cancer patients? Review. Cancer Epidemiol Biomarkers Prev. 2006; 15: 194–202
  • Rehli M, Niller H-H, Ammon C, Langmann S, Schwarz-Fischer L, Andreesen R, et al. Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. J Biol Chem. 2003; 278: 44058–67
  • Volck B, Price PA, Johansen JS, Sørensen O, Benfield T, Calafat J, et al. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Phys. 1998; 110: 351–60
  • Malinda KM, Ponce L, Kleinman HK, Shackelton LM, Millis AJT. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res. 1999; 250: 168–73
  • Nishikawa KC, Millis AJT. gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res. 2003; 287: 79–87
  • Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Østergaard M, et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage. 2001; 9: 203–14
  • Boot RG, van Achterberg TAE, van Aken BE, Renkema GH, Jacobs MJHM, Aerts JMFG, et al. Strong induction of members of the chitinase family of proteins in atherosclerosis. Chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol. 1999; 19: 687–94
  • Kronborg G, Østergaard C, Weis N, Nielsen H, Obel N, Pedersen SS, et al. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated to the outcome of the disease. Scand J Infect Dis. 2002; 34: 323–6
  • Johansen JS, Krabbe K, Møller K, Pedersen BK. Circulating YKL-40 levels during human endotoxaemia. Clin Exp Immunol. 2005; 140: 343–8
  • Vind I, Johansen JS, Price PA, Munkholm P. Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol. 2003; 38: 599–605
  • Johansen JS, Baslund B, Garbarsch C, Garbarsch C, Hansen M, Stoltenberg M, et al. YKL-40 in giant cells and macrophages from patients with giant cell arteritis. Arthritis Rheum. 1999; 42: 2624–30
  • Rathcke CN, Johansen JS, Vestergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res. 2006; 55: 53–9
  • Kucur M, Isman FK, Karadag B, Vural VA, Tavsanoglu S. Serum YKL-40 levels in patients with coronary artery disease. Coronary Artery Dis. 2007; 18: 391–6
  • Scheidl SJ, Nilsson S, Kalen M, Hellstrom M, Takemoto M, Hakansson J, Lindahl P. mRNA expression profiling of laser microbeam microdissected cells from slender embryonic structures. Am J Pathol. 2002; 160: 801–13
  • Wang Y, Gabrielsen A, Lawler P, Brown LF, Paulsson-Berne G, Hansson GK, et al. Myocardial gene expression of angiogenic factors in human chronic ischemic heart disease-influence of acute ischemia/cardioplegia and reperfusion. Microcirculation. 2006; 13: 187–97
  • Nøjgaard C, Høst NB, Christensen IJ, Poulsen SH, Egstrup K, Price PA, et al. Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coronary Artery Dis. 2008;19:257–63.
  • Junker N, Johansen JS, Hansen LT, Lund EL, Kristjansen PG. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Cancer Sci. 2005; 96: 183–90
  • Johansen JS, Milman N, Hansen M, Garbarsch C, Price PA, Graudal N. Increased serum YKL-40 in patients with pulmonary sarcoidosis. A potential marker of disease activity?. Respir Med. 2005; 99: 396–402
  • Recklies AD, White C, Ling H. The chitinase 3-like protein human cartilage 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase-and protein kinase B-mediated signalling pathways. Biochem J. 2002; 365: 119–26
  • Bigg HF, Wait R, Rowan AD, Cawston TE. The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation. J Biol Chem. 2006; 281: 21082–95
  • Braunwald E, Kloner RA. Myocardial reperfusion: A double edged sword. J Clin Invest. 1985; 76: 1713–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.